Jennifer L. Taubert - Feb 13, 2023 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, WW Chair, Pharmaceuticals
Signature
Raavi K. Deol, as attorney-in-fact for Jennifer L. Taubert
Stock symbol
JNJ
Transactions as of
Feb 13, 2023
Transactions value $
-$1,712,284
Form type
4
Date filed
2/15/2023, 06:25 PM
Previous filing
Feb 14, 2023
Next filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Award $0 +21.4K +16.64% $0.00 150K Feb 13, 2023 Direct F1
transaction JNJ Common Stock Tax liability -$1.71M -10.6K -7.04% $162.01 140K Feb 13, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Employee Stock Options (Right to Buy) Award $0 +64.6K $0.00 64.6K Feb 13, 2023 Common Stock 64.6K $162.75 Direct F2
transaction JNJ Restricted Share Units Award $0 +3.91K $0.00 3.91K Feb 13, 2023 Common Stock 3.91K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Common Stock received upon the satisfaction of performance and time-based criteria for Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 10, 2020.
F2 Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.
F3 Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock.
F4 The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.